Latest Leadership And Governance News

Tetratherix Limited reported a $9.4 million statutory loss for FY25 amid significant R&D and operational investments, successfully listing on the ASX and progressing multiple clinical and manufacturing initiatives.

Paladin Energy’s 2025 Annual Report reveals a pivotal year marked by operational ramp-up at Namibia’s Langer Heinrich Mine and the strategic acquisition of Fission Uranium in Canada, positioning the company for multi-decade growth amid a tightening uranium market.

IDP Education Limited reported a 15% revenue decline and a 66% drop in net profit for FY25, driven by sustained policy restrictions across key international student markets. The company is responding with a multi-year transformation program focused on cost reduction and AI-driven innovation.

NextEd Group Limited reported a 13.9% revenue decline to $95.9 million for FY25 but achieved a 53% improvement in net loss after tax, driven by cost savings and operational efficiencies. The company’s strategic repositioning includes leadership changes and expanded vocational offerings.

Mayfield Group Holdings has raised its fully franked final dividend to 2.2 cents per share for FY25, reflecting solid financial health and promising ongoing shareholder returns.

Invion Limited posted a $8.8 million loss for FY25, marking a 56.5% increase, while advancing clinical trials and securing fresh capital. The biotech faces a going concern warning amid ongoing development and funding challenges.

M3 Mining Limited has announced a significant leadership renewal alongside a strategic review aimed at streamlining operations, reducing costs, and focusing on high-value exploration assets.

WiseTech Global reported a robust FY25 with 14% revenue growth and a 17% rise in net profit, underpinned by a transformative $2.1 billion acquisition of e2open and strategic leadership changes.

Tabcorp Holdings Limited has reported a significant financial turnaround for FY25, driven by the new Victorian Wagering and Betting Licence and strategic operational improvements. The company posted $2.6 billion in revenue and a net profit after tax of $36.6 million, reversing last year's substantial loss.

McPherson’s Limited reported a 3.9% revenue decline to $139 million in FY25 amid a strategic shift to a pharmacy wholesaler model, posting a $15 million net loss but signaling moderate EBITDA growth ahead.

AdAlta Limited reported a reduced net loss of $4.5 million for FY2025 but flagged material uncertainty over its ability to continue as a going concern, with no dividends declared.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.